HeroSupport
Non Equity Assistance in 2024
HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.
Aseptuva
Non Equity Assistance in 2024
Aseptuva is an early-stage MedTech startup located in Technopark Winterthur, focused on combating Healthcare-Associated Infections (HAI). The company addresses the critical issue of catheter-related infections that can lead to severe complications, including pneumonia and bloodstream infections, which claim thousands of lives annually and incur significant healthcare costs. Aseptuva is developing a range of medical devices designed for in-situ disinfection of various catheters, effectively preventing the onset of infections in healthcare settings. By providing an automated system for disinfection, Aseptuva aims to support medical staff in reducing the risk of hospital-acquired infections, thereby improving patient outcomes and potentially saving thousands of lives each year. Through its innovative technology, the company aspires to establish a new standard in critical care and make a meaningful impact on global health.
Selmod
Non Equity Assistance in 2021
Selmod, located in Basel, Switzerland, specializes in the development of innovative small molecule therapies aimed at treating life-threatening, multi-drug resistant infections. The company is committed to discovering and advancing first-in-class drug candidates that provide second-line and last-resort treatment options for patients in hospital settings, particularly where conventional therapies have failed due to resistance. Selmod's approach includes the development of antibiotics with dual modes of action to effectively counteract existing resistance mechanisms. Its leading candidates, SLM500, SLM100, and SLM300, have demonstrated success in preclinical animal studies and are positioned within a promising market projected to exceed $9 billion. The company aims to capture a substantial market share shortly after entry, supported by a leadership team with extensive experience in clinical development for major pharmaceutical firms. Funding will be utilized to advance SLM500 through IND-enabling studies and to optimize additional lead candidates for further development.
Munevo
Non Equity Assistance in 2021
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company's flagship product, munevo DRIVE, is a Smartglass application designed to control electric wheelchairs through the user's head movements, allowing for hands-free operation. This technology enables users to navigate both indoors and outdoors, promoting greater independence and mobility. In addition to its core product, Munevo also provides adaptors and accessories to support its solutions, further empowering individuals with mobility impairments.
Plastogaz
Non Equity Assistance in 2021
Plastogaz is a Swiss company based in Lausanne that specializes in the production of natural gas from waste resources, particularly synthetic waste streams like plastics. Founded in 2019, it utilizes a patented catalyst technology to convert mixed plastics into grid-compatible methane and naphtha, which can serve as fuel or be used for creating new synthetic materials. By transforming plastic waste into usable products, Plastogaz aims to mitigate greenhouse gas emissions and contribute to a more sustainable environment. The company's innovative approach not only addresses the challenges of plastic disposal but also helps reduce the carbon footprint associated with traditional waste management practices.
Eaternity
Non Equity Assistance in 2021
Eaternity AG is a Zurich-based company that specializes in software management solutions tailored for the restaurant industry. Founded in 2014, it provides tools that enable restaurant owners to gain valuable insights into their supply chain, enhancing decision-making processes. Eaternity's platform features a real-time calculation engine that facilitates allergen and nutrition declarations while also assessing the carbon footprint of meals and restaurants. This functionality empowers organizations globally to accurately calculate the environmental impact of their food offerings, promoting transparency and informed choices among consumers and decision-makers. Eaternity's mission centers on fostering a sustainable food system that operates within planetary boundaries.
VAY
Non Equity Assistance in 2021
VAY is a Zurich-based computer vision company that specializes in human motion analysis, utilizing advanced technology to digitize human movements through a simple camera. Founded in 2019, VAY develops innovative solutions that make products smarter, more interactive, and immersive by leveraging real-life data and feedback. Their platform employs artificial intelligence to accurately perceive and predict human motion, facilitating seamless interaction between digital systems and users. The company's hardware and system agnostic approach allows for versatile applications across various sectors, including health, sports, and gaming, providing valuable insights for physiotherapy, rehabilitation, and gait or posture analysis.
Oxyle
Non Equity Assistance in 2021
Oxyle AG, established in 2020 and headquartered in Zurich, Switzerland, specializes in wastewater treatment solutions. The company offers services to diverse industries including pharmaceuticals, chemicals, food & beverage, research labs, electronics, hospitals, and wastewater plants. Oxyle's proprietary technology eliminates persistent micropollutants such as pharmaceuticals, pesticides, endocrine disruptors, color pigments, and industrial chemicals from wastewater. This helps clients comply with regulations, reduce CO2 emissions by avoiding wastewater incineration, and protect water bodies from toxic pollutants.
Authena
Non Equity Assistance in 2021
Authena is a company based in Zug, Switzerland, specializing in product authentication and traceability solutions. It combines proprietary IoT devices with blockchain and AI technologies to provide real-time, unit-level tracking for industries such as Pharmaceuticals, Luxury, and Food and Beverage. Authena's solutions, including Authena SHIELD™ and Authena L1VE (Next Generation), ensure regulatory compliance while fostering consumer trust through transparency, authenticity, and sustainability. The company's platform monitors environmental conditions and secures product information with immutable records, helping brands protect against counterfeiting, diversion, and fraud. By enhancing supply chain visibility and reducing distribution costs, Authena enables brands to improve their financial performance and build stronger customer relationships.
NaturLoop
Non Equity Assistance in 2021
NaturLoop is a Swiss-based cleantech and material science company focused on promoting sustainable development through the production of natural biocomposites. The company specializes in manufacturing coconut-based fiberboards derived from agricultural waste, utilizing an innovative and low-tech process to create eco-friendly materials. By leveraging existing wood panel infrastructure, NaturLoop offers versatile and high-performance alternatives for the construction sector, addressing environmental concerns and supporting circular economy practices. Its unique turnkey micro-factory concept enables the industrial-scale production of these biocomposites, while also integrating local rural communities into the value chain. Through its efforts, NaturLoop aims to provide accessible and affordable sustainable options, mitigating the depletion of natural resources.
Munevo
Non Equity Assistance in 2021
Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company's flagship product, munevo DRIVE, is a Smartglass application designed to control electric wheelchairs through the user's head movements, allowing for hands-free operation. This technology enables users to navigate both indoors and outdoors, promoting greater independence and mobility. In addition to its core product, Munevo also provides adaptors and accessories to support its solutions, further empowering individuals with mobility impairments.
Lyfegen
Non Equity Assistance in 2020
Lyfegen is a global provider of drug access, pricing, and rebate management services, with headquarters in Basel, Switzerland, and Boston, USA. The company offers a platform that assists healthcare payers, pharmaceutical companies, and medical technology providers in developing effective pricing agreements for medicines and streamlining the management of drug rebates. By leveraging advanced software, Lyfegen enables clients to collect, analyze, and reconcile diverse healthcare data, facilitating automation in value-based healthcare contracting. This approach aims to enhance access to treatments, improve patient health outcomes, and increase affordability in the healthcare sector.
Readily3D
Pre Seed Round in 2020
Readily3D is a Swiss company based in Lausanne that specializes in volumetric 3D printing solutions. Founded in 2020 as a spin-off from the École Polytechnique Fédérale de Lausanne (EPFL), the company has developed an innovative technology that allows for the rapid manufacturing of complex objects in less than 30 seconds using tomography. Readily3D focuses on creating patient-specific devices, such as comfortable orthoses for individuals with hearing loss and surgical models for medical professionals. Its platform utilizes a liquid photosensitive polymer that is illuminated from multiple angles with dynamic light patterns, enabling the production of customized, elastic materials. This technology aims to enhance patient care and streamline surgical planning for healthcare providers.
Exomotion
Non Equity Assistance in 2020
Exomotion SA is a Swiss company founded in 2018, located in Plan-les-Ouates, Geneva. The company specializes in the development of innovative personal mobility devices that utilize robotics technology. Exomotion's products are designed to enhance omnidirectional movement, featuring electronic movement systems that combine electrical boards with motion sensors and a wheeled mechanism. This technology enables the devices to move in any direction and rotate instantly, significantly improving the user experience. By rethinking the concept of e-mobility, Exomotion aims to enhance mobility solutions with a focus on omnidirectionality and safety.
Synthara
Non Equity Assistance in 2020
Synthara AG is a Swiss semiconductor startup specializing in the development of smart sensors for industrial Internet of Things (IoT) and energy-efficient applications. Founded in 2019 and headquartered in Zurich, the company focuses on creating advanced computational AI chips that enhance the performance of embedded systems. Its flagship product, ComputeRAM, functions as a drop-in replacement for traditional SRAM, enabling complex calculations directly in memory. This innovation significantly reduces CPU workload and enhances system efficiency, particularly for AI-driven applications. Synthara's technology is processor-type agnostic, compatible with various architectures including RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By offering solutions that lower costs and accelerate time to market, Synthara aims to empower chipmakers and device manufacturers to explore new opportunities in sectors such as wearables, biomedical monitoring, and autonomous navigation.
Amphasys
Non Equity Assistance in 2020
Amphasys is a technology company that specializes in the development and marketing of innovative, chip-based single-cell analysis technology. Founded in 2012 as a spin-off from Axetris AG, the company focuses on simplifying, accelerating, and miniaturizing complex cell analyses, making them accessible for use outside traditional laboratory settings. The technology, initially developed in collaboration with the Swiss Federal Institute of Technology Lausanne in 2004, has been validated through extensive research with various cell types and is currently employed in applications such as pollen quality monitoring and milk analysis. By eliminating the need for time-consuming and complex sample preparation steps, including cell labeling, Amphasys enables clients to conduct label-free analyses of single-cell characteristics such as size, morphology, viability, and differentiation. The company has received recognition for its innovations, including the prestigious Swiss startup prize awarded by the W.A. de Vigier Foundation in 2013.
aquama
Non Equity Assistance in 2020
Created in Switzerland, Aquama® offers an innovative solution for cleaning and disinfecting with electrified water and salt, within an application system (Apple / Google/ Huawei). Thanks to this technology, professionals and individuals benefit from a detergent and disinfectant solution, at a competitive price and without toxicity. A revolution that allows both to limit costs and reduce pollution. ECOLOGY, ECONOMY AND EFFICIENCY Born in the hospitality sector, Willy Lionel Pomathios began to take an interest in ecology 10 years ago. In 2013, thanks to his collaboration with Aquama® engineers, he created a detergent and disinfectant solution consisting only of water, salt and electricity. Thanks to this hydrolysis process, water is rid of all chemical and toxic substances, a real revolution in the field of cleaning.
Smeetz SA is a Swiss-based company that operates an online booking platform designed for the leisure and entertainment industry. Established in 2016 and headquartered in Lausanne, Smeetz offers an AI-powered commerce intelligence platform that integrates various tools for ticketing, payment processing, and event management. Its comprehensive solutions include features such as dynamic pricing, data analytics, reservation management, and cross-channel sales, all aimed at enhancing operational efficiency and maximizing revenue for venues. By leveraging insights derived from artificial intelligence, Smeetz empowers event organizers to optimize marketing strategies and improve guest experiences, thereby facilitating the digital transformation of the leisure sector.
Hi-D Imaging
Non Equity Assistance in 2020
Hi-D Imaging AG is a Swiss company established in 2019, specializing in advanced imaging technologies for cardiovascular disease, particularly focusing on heart valve replacement. The company offers a SaaS-based pre-operational planning platform that assesses the hemodynamics of patient-specific anatomies. This platform enables physicians to analyze blood flow patterns and select the optimal size and shape of heart valves prior to trans-catheter aortic valve implantation. By providing detailed imaging and in-vitro fluid dynamic analysis, Hi-D Imaging empowers medical professionals to make data-driven decisions tailored to individual patient needs, thereby improving surgical outcomes and reducing the necessity for additional medical imaging. The company is headquartered in Winterthur, Switzerland.
Automation Hero
Non Equity Assistance in 2020
Automation Hero, Inc. is a technology company that specializes in developing an artificial intelligence-based platform aimed at automating sales processes. Founded in 2017 and based in San Francisco, with additional offices in Berlin and Halle, the company offers a range of tools including Viz Studio, which enables users to visualize and optimize complex processes; Hero_Go, a screen automation tool that records user interactions; and Flow Studio, designed for custom solution development. The company also features AI Studio, which addresses limitations of traditional robotic process automation, and a domain-intelligent OCR that digitizes various types of documents. Their application, Robin, streamlines the sales process by providing leads and automating meeting scheduling. Automation Hero serves diverse industries such as insurance, banking, high tech, retail, manufacturing, telecom, and media, and it works with organizations ranging from Fortune 100 companies to rapidly growing startups. The company was previously known as SalesHero, Inc. before rebranding in March 2019.
PXL Vision AG, established in 2017 and headquartered in Zurich, Switzerland, specializes in designing and developing advanced identity verification software solutions. Its flagship product, Daego, is a cross-platform solution that creates trusted digital identities for customer onboarding through sophisticated document and identity verification using computer vision and machine learning technologies. PXL Vision operates research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, serving industries such as insurance, gambling, fintech, banking, and healthcare worldwide. The company aims to reduce customer onboarding costs, enhance conversion rates, and prevent fraud by providing unbiased, verifiable identities for secure digital interactions.
CellSpring is a biotechnology company based in Zurich, Switzerland, specializing in the development of 3D micro tissues for diverse biological applications. Its primary technology, the 3D Bloom platform, allows for the rapid creation of biomimetic microtissues that are not dependent on specific cell types. This innovative platform enhances existing 3D cell culture methods by offering improved speed, reliability, versatility, and user-friendliness. By facilitating the production of these advanced microtissues, CellSpring aims to support in vitro studies and contribute to advancements in clinical diagnostics, including the early detection of cancer.
Artiria Medical
Grant in 2019
Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.
Enterprise Bot
Grant in 2019
Enterprise Bot GmbH is a company that specializes in developing artificial intelligence-powered chatbots aimed at automating customer interactions for enterprises. Founded in 2017 and headquartered in Zug, Switzerland, with an additional office in Bengaluru, India, the company offers a range of products, including chatbots for sales and customer service, email triage bots, and scheduling assistants. Enterprise Bot's solutions are particularly tailored for financial institutions and insurance enterprises, helping to enhance customer experience while significantly reducing operational costs and wait times. By providing a multi-platform messenger that allows for natural language communication, the company enables businesses to effectively address a wide array of customer needs and queries.
Planted Foods
Grant in 2019
Planted Foods AG is a Swiss company founded in 2019, specializing in the development of plant-based meat alternatives. The company produces products such as planted chicken and BBQ planted chicken, utilizing a formulation that includes pea protein, pea fiber, sunflower oil, and water to replicate the taste, texture, and mouthfeel of traditional animal meat. Planted Foods employs advanced technology to transform these natural ingredients into nutritious, high-protein meat substitutes that appeal to consumers seeking plant-based options. In addition to its product offerings, the company operates an e-commerce platform to facilitate direct sales to customers. Headquartered in Zürich, Switzerland, Planted Foods is committed to providing delicious and sustainable meat alternatives.
CrystalsFirst
Non Equity Assistance in 2019
CrystalsFirst GmbH is a biotechnology company based in Marburg, Germany, founded in 2018, that specializes in protein crystal stabilization methodologies to enhance drug candidate screening. The company offers innovative technologies, including SmartSoak, which is designed for screening small molecule arrays to identify novel lead candidates, and SmartLib, a compound library for fragment-based drug discovery. Additionally, CrystalsFirst provides SmartRefine, a software solution for the automated refinement of crystallographic diffraction data. Their MAGNET platform integrates high-performance structural biology, computational modeling, and machine learning to address limitations in small molecule drug discovery. By utilizing three-dimensional models and a "crystal structure first" strategy, the company enables the rational design of therapeutic compounds, facilitating rapid access to diverse chemical scaffolds and optimizing lead candidates. CrystalsFirst serves pharmaceutical companies by accelerating the drug discovery process and enhancing the likelihood of finding effective new treatments.
Terapet
Non Equity Assistance in 2019
Terapet SA is a Switzerland-based company founded in 2019 at CERN by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals. The company specializes in developing advanced proton therapy technology for cancer treatment, which allows for precise targeting of tumors while minimizing damage to surrounding healthy tissue. This innovative approach leverages the unique properties of protons, which stop at a predetermined depth within the patient, enabling the delivery of a concentrated dose to the tumor. Terapet's system also provides real-time, three-dimensional monitoring of the proton dose administered, enhancing treatment accuracy and safety. With a focus on making cutting-edge cancer therapy more accessible and cost-effective, Terapet is preparing for the market launch of its initial product.
Regenosca
Non Equity Assistance in 2019
Regenosca SA is a Swiss company based in Lausanne, established in 2019, that specializes in the development and commercialization of innovative medical devices for bladder reconstruction. The company focuses on creating sterile, off-the-shelf implants that serve as viable alternatives to autologous tissue substitutes for soft tissue repair. By leveraging advanced biomaterials technology, Regenosca aims to facilitate regeneration rather than scarring, thereby enhancing patient outcomes and preserving bladder function. Their products are designed to be easy to use, ultimately improving the quality of life for patients undergoing bladder surgeries.
Watttron
Non Equity Assistance in 2019
Watttron GmbH is a technology company based in Freital, Germany, that specializes in the development and production of advanced heating systems designed for applications requiring high precision in temperature control. Established in 2016, Watttron offers innovative matrix heating and sealing systems, as well as customized heating solutions and simulation services. Its patented technology allows for heterogeneous heating, which is beneficial in various industrial processes, including polymer processing, packaging, additive manufacturing, microelectronics, biotechnology, automotive, and medicine. The company's focus on energy efficiency and precise temperature management enables clients to effectively process bio-based and recycled materials, positioning Watttron as a leader in the field of intelligent heating solutions.
Plair SA
Non Equity Assistance in 2019
Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.
Dimpora
Non Equity Assistance in 2019
Dimpora AG, based in Zürich, Switzerland, specializes in the design and manufacture of eco-friendly functional membranes for the outdoor textile industry. The company produces waterproof, fluorine-free membranes primarily made from polyurethane, utilizing a template removal approach to create porosity that enhances breathability. Dimpora's innovative technology allows for the direct application of membranes onto various surfaces, facilitating fast moisture transport while ensuring complete rain protection. Committed to sustainability, Dimpora aims to develop high-performance membranes that enable outdoor enthusiasts to enjoy nature responsibly, with a focus on creating next-generation solutions that may incorporate recyclable materials.
Hempfy
Non Equity Assistance in 2019
Hempfy is a Swiss company specializing in the production of innovative, THC-free hemp-infused food and beverages. Utilizing proprietary cold infusion technology, Hempfy cultivates, harvests, and processes hemp plants in compliance with Swiss legislation. All products are 100% Swiss-made, with a focus on bespoke quality, from seed selection to final production. Hempfy aims to replace smoking and alcohol as the world's preferred social drug, offering cannabis-based products with a balanced taste and light carbonation.
iWin
Non Equity Assistance in 2019
iWin, based in Manno, Switzerland, specializes in the development of an innovative photovoltaic venetian-blind shading device that is seamlessly integrated into insulating windows without affecting their design or functionality. Established in 2019, the company aims to enhance building sustainability, as the construction sector is responsible for approximately 40% of global CO2 emissions. The patented system not only generates renewable energy on-site but also effectively controls light and solar radiation, protecting buildings from overheating in summer. iWin’s product is customizable in size and color, durable, and requires minimal maintenance, boasting a payback period of less than ten years. The company has created its first working prototype and has formed partnerships with SUPSI and Pellini Group, a leader in integral venetian blinds. With a significant market opportunity, particularly in Switzerland where around 900,000 square meters of glass façades are installed annually, iWin is poised for growth in the sustainable building sector.
Dronistics
Non Equity Assistance in 2019
Dronistics is a Swiss company based in Lausanne that specializes in developing a personal and user-friendly drone delivery system designed for last-centimeter delivery to hard-to-reach locations. Its innovative system utilizes autonomous drones, which are equipped with GPS technology and controlled through a web application accessible on various devices, including smartphones, tablets, and laptops. The drones are connected to the internet via a 4G modem, enabling seamless operation. To ensure safety during flights and while unloading packages, Dronistics incorporates a series of safety checks into its software. This technology allows logistics and online retail companies to effectively address delivery challenges in remote areas, providing a reliable solution for modern delivery needs.
Microcaps
Non Equity Assistance in 2019
Microcaps AG is a company based in Zurich, Switzerland, founded in 2018, specializing in the development of advanced microencapsulation technology. The firm focuses on creating devices that facilitate the precise production of monodisperse microcapsules and microparticles through innovative microfluidics. Microcaps' solutions are designed to enhance drug delivery systems and probiotic encapsulation, while also providing tailored offerings for various applications, including pharmaceuticals and cosmetics. Their cutting-edge technology enables scalable, fully-automated production that allows for size control, precise dosing, and improved stability of the encapsulated materials. By utilizing a step emulsification device, Microcaps enhances production capacity and throughput rates without compromising quality, making it a pivotal player in the field of microencapsulation.
OxyPrem
Non Equity Assistance in 2019
OxyPrem AG is a Swiss company that specializes in the development, design, and manufacturing of advanced sensor solutions specifically for monitoring preterm infants. Established in 2018 and headquartered in Zurich, the company offers a reusable device that continuously measures hemoglobin oxygen saturation in the brains of high-risk preterm infants. By utilizing harmless near-infrared light technology, OxyPrem provides real-time monitoring, which significantly enhances the clinical care provided to this vulnerable patient group. The innovations from OxyPrem aim to prevent early death and severe long-term brain damage, thereby minimizing the risk of disabilities and other complications associated with premature birth.
Clemedi
Non Equity Assistance in 2019
Clemedi AG is a Swiss-based company founded in 2018 that specializes in developing diagnostic workflows for infectious diseases. The company creates in vitro diagnostic tests by integrating next-generation sequencing and machine learning technologies. These innovative tests are designed to diagnose drug-resistant infections directly from patient samples within a single day, supporting timely and personalized antibiotic therapy. By providing healthcare professionals with critical information, Clemedi aims to enhance decision-making in the treatment of infectious diseases, ultimately contributing to the fight against antibiotic resistance. This approach is particularly significant given projections that antibiotic-resistant bacteria could lead to 10 million deaths annually by 2050.
Logmind
Non Equity Assistance in 2019
Logmind Ltd is a company based in Lausanne, Switzerland, that specializes in developing a cloud-based data analytics platform focused on unstructured log data. Founded in 2018, Logmind's platform provides visibility and automated insights that help organizations manage complex IT infrastructures. The solution features capabilities such as real-time error detection, automated recommendations, and visualization dashboards, enabling clients to identify and resolve technical issues effectively. By transforming unorganized datasets into operational intelligence, Logmind empowers IT operations and DevOps teams to maintain application performance, minimize downtime, and prevent costly incidents.
Authena
Non Equity Assistance in 2019
Authena is a company based in Zug, Switzerland, specializing in product authentication and traceability solutions. It combines proprietary IoT devices with blockchain and AI technologies to provide real-time, unit-level tracking for industries such as Pharmaceuticals, Luxury, and Food and Beverage. Authena's solutions, including Authena SHIELD™ and Authena L1VE (Next Generation), ensure regulatory compliance while fostering consumer trust through transparency, authenticity, and sustainability. The company's platform monitors environmental conditions and secures product information with immutable records, helping brands protect against counterfeiting, diversion, and fraud. By enhancing supply chain visibility and reducing distribution costs, Authena enables brands to improve their financial performance and build stronger customer relationships.
EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.
Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.
Resistell AG is a Swiss company founded in 2018, based in Muttenz, specializing in the development and marketing of innovative diagnostic devices for antibiotic susceptibility testing. The company's platform employs advanced nanomotion technology to detect the movement of living bacterial cells, allowing for the rapid identification of bacterial resistance to antibiotics. This method serves as an alternative to traditional culture-based antibiograms, enabling healthcare providers to administer appropriate antibiotics in a timely manner, ultimately improving patient outcomes.
Biospectal is a remote patient monitoring and biosensing software company that has developed the OptiBP smartphone app, which allows users to measure and monitor blood pressure with medical-grade accuracy using their smartphones. The app utilizes the phone's built-in camera to optically measure blood flow from the user's fingertip, providing results in approximately 20 seconds, which is significantly faster than traditional blood pressure cuffs. Biospectal's proprietary algorithms interpret the captured data to deliver accurate blood pressure readings. The OptiBP app is currently available in public beta for Android users in several countries, including the United States, United Kingdom, France, Germany, Spain, and Switzerland. This innovative approach enables users to perform blood pressure measurements anytime and anywhere without the need for additional devices or accessories.
Securaxis
Pre Seed Round in 2018
Securaxis develops, installs, and operates innovative safety and security solutions, focusing on real-time geolocalized security information. Founded in 2018 as part of the BIC of CERN Technologies in Switzerland, the company is recognized for its achievements, including participation in various startup programs and awards. Securaxis utilizes a smart acoustic sensor connected to a wireless network to analyze and classify sounds in urban environments, allowing for accurate reporting of potential security threats. This technology enables organizations to enhance safety measures by making informed decisions based on real-time data. The team consists of eight experts in machine learning, acoustics, data management, and entrepreneurship, who have successfully developed and commercialized a mobile security application for notable clients, including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations.
Akselos
Venture Round in 2018
Akselos S.A., founded in 2011 and based in Lausanne, Switzerland, specializes in advanced engineering simulation software, specifically its Integra platform. This cloud-based solution allows engineering firms to create high-resolution digital twins of large-scale operational assets, enabling detailed analysis of structural integrity and hydrodynamic performance. Akselos's technology is particularly beneficial for asset-centric industries such as upstream oil and gas and offshore wind, where real-time monitoring and predictive maintenance are critical. The platform's patented algorithms provide simulations that are significantly faster than traditional methods, allowing for efficient design and management of critical infrastructure. Akselos also operates a subsidiary in Cambridge, Massachusetts, and maintains a representative office in Vietnam, underscoring its global presence in providing innovative simulation solutions.
ROVENSO
Non Equity Assistance in 2018
ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.
Nagi Bioscience
Non Equity Assistance in 2018
Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.
Bloom Biorenewables
Non Equity Assistance in 2018
Bloom Biorenewables Ltd is a Swiss company established in 2019, specializing in the development of innovative technologies that convert wood and agricultural waste into renewable materials as substitutes for petroleum-based products. The company focuses on producing bio-based materials for various sectors, including fragrances, plastics, and textiles, thereby offering sustainable alternatives to fossil fuels. By introducing a novel approach to the production of biorenewable products and fuels, Bloom Biorenewables aims to make a significant impact in promoting the use of sustainable resources and addressing climate change challenges.
Lab-on-Fiber
Non Equity Assistance in 2018
Lab-on-Fiber GmbH is a German company based in Halle that specializes in the development, commercialization, and production of advanced fiber delivery and laser systems for medical applications. The company focuses on creating smart medical laser probes that are designed to enhance outcomes in minimally invasive surgeries. Its product offerings include surgical and urology fiber probes, which utilize optimized radiation profiles and temperature monitoring at the probe surface. These innovations aim to improve patient safety, reduce operating times, and increase the success rate of treatments, thereby addressing key challenges in laser surgery.
Aspivix
Non Equity Assistance in 2018
Aspivix SA is a Swiss company founded in 2015, specializing in the development of minimally invasive surgical instruments for gynecology. Headquartered in Lausanne, the firm focuses on creating a new generation of medical devices that enhance the safety and comfort of gynecological procedures. Its flagship product, CAREVIX, employs innovative suction technology to facilitate the painless placement of intra-uterine contraceptive devices and other gynecological interventions. This device is specifically designed to reduce cervical bleeding and minimize the risk of lesions and cross-infections, ultimately safeguarding patient health. By replacing traditional methods such as the use of forceps with its patented suction pad technology, Aspivix aims to transform gynecological care, providing gentler solutions for both women and healthcare providers.
Kejako
Non Equity Assistance in 2018
Kejako SA is a Swiss company, founded in 2015 and based in Plan-les-Ouates, that specializes in the research and development of medical devices for the ophthalmic surgery sector. The company focuses on addressing presbyopia, a condition that leads to the gradual loss of visual accommodation, through innovative solutions. Kejako offers a unique, non-invasive approach that combines simulation and minimally invasive treatment techniques, utilizing a full eye 3D parametric model and multi-physics numerical modeling to accurately compute the eye's optical and mechanical behavior. This technology enables patients to plan and control customized procedures aimed at preserving their quality of life as they age.
ALAnostics
Non Equity Assistance in 2018
ALAnostics is a specialty biopharmaceutical company that originated as a spin-off from the University of Geneva. It focuses on developing innovative tumor painting technology aimed at enhancing the surgical treatment of breast cancer. The company’s proprietary approach utilizes nanomedicines to create a fluorescent dye that targets early-stage tumors, facilitating real-time identification and removal during surgery. This technology, based on 5-ALA prodrugs, supports fluorescence-guided surgical procedures and incorporates light-activated antimicrobials, ultimately improving surgical outcomes and increasing the likelihood of saving patients' lives by ensuring complete tumor removal.
Aesyra
Non Equity Assistance in 2018
Aesyra SA is a Swiss company founded in 2017 and headquartered in Lausanne. It specializes in the design and manufacture of medical devices, particularly the AesyBite, an intra-oral sensor that monitors and alleviates sleep bruxism. Aesyra's technology is aimed at assisting dental professionals by reducing damage to dental prostheses caused by occlusal issues. The company focuses on enhancing the care of individuals with sleep disorders by providing tools that perform intraoral measurements during sleep. These measurements help in detecting bruxism, obstructive sleep apnea, and other related conditions. Through its innovative solutions, Aesyra enables healthcare professionals to accurately monitor patient activities and implement biofeedback treatments to improve sleep quality.
Flyla
Non Equity Assistance in 2018
FLYLA GmbH, founded in 2018 and based in Munich, Germany, specializes in providing online booking solutions tailored for students and young travelers. The company connects with airlines to establish student fares, which serve as a revenue management tool, and distributes these fares to its expanding network of enrolled university students. By simplifying travel arrangements through its online booking software, FLYLA enables users to access discounted travel deals, facilitating bookings by allowing the submission of travel details and online payments. This approach addresses the financial constraints many students face in affording air travel, thereby promoting greater access to travel opportunities for the youth.
Rapid Graft
Non Equity Assistance in 2018
Rapid Graft, established in 2018 and based in Zurich, Switzerland, specializes in developing innovative medical devices for precise skin graft harvesting. Their flagship product is a novel dermatome designed to efficiently obtain small split-skin grafts, aiming to enhance chronic wound treatment and facilitate future tissue engineering needs. The company's device enables surgeons to perform skin grafting procedures more effectively, minimizing the risk of infection, scarring, and requiring fewer specialized interventions or operating room resources.
Parquery
Non Equity Assistance in 2018
Parquery AG is a Swiss start-up based in Zurich, founded in 2014. The company specializes in smart parking solutions through its cloud-based image analysis software. Utilizing computer vision and machine learning, Parquery's technology processes images from existing cameras to detect real-time availability of on-street parking spaces. This innovative web application provides users with real-time vacancy data and smart routing options, aiding drivers in locating available parking spots efficiently. Additionally, Parquery's solutions offer parking managers insights into the historical, current, and predictive usage of their facilities, contributing to enhanced smart city and smart mobility initiatives.
Letos
Non Equity Assistance in 2018
Letos is a computer software startup founded in 2016 and based in Brandenburg, Germany. The company specializes in behavioral sciences, affective neuroscience, and well-being technologies. Letos develops machine learning technology that predicts user behavioral reactions through the use of biosensors and advanced machine learning techniques. This platform captures genuine spontaneous emotional responses, allowing organizations to assess user satisfaction, alertness, and overall well-being while ensuring total user anonymity. By focusing on technological advancements that prioritize the human user, Letos aims to enhance understanding of user experiences in various contexts.
MEMBRASENZ GmbH
Grant in 2017
MEMBRASENZ GmbH was founded in June 2015 by Dr. Jelena Stojadinovic and Prof. Dr. Fabio La Mantia. The company's mission is to supply innovative gas separator solutions for electrolyzers’ industry and make hydrogen universally accessible. Moreover, MEMBRASENZ’s vision is to be the supplier of resource supporting products enabling the sustainability of sense and integrity based energy systems. The company is a spin-off of the Center for Electrochemical Sciences at the Ruhr-University Bochum. MEMBRASENZ has been supported by German Ministry of Economy and Energy BMWi (EXIST grant), Cluster of Excellence RESOLV "Ruhr Explores Solvation" and Horizon 2020 EU Framework Programme for Research and Innovation.
GliaPharm SA is a Swiss biotechnology company focused on developing innovative treatments for neurological and psychiatric disorders. Established in 2016 and headquartered in Geneva, GliaPharm specializes in targeting glial cells, which are the support cells of neurons, to enhance brain metabolism in pathological conditions. The company utilizes its GliaX technology platform to identify drugs that influence glial cell activity and brain energy metabolism. This platform incorporates high throughput screening technologies, metabolic tests for in vitro and in vivo assessments, and various rodent models to study neurological diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, and other psychiatric conditions. Through its research and development efforts, GliaPharm aims to provide healthcare providers with novel therapeutic options for patients suffering from these disorders, positioning itself as a leader in glia-mediated neuroprotection and cognitive function maintenance.
GuestLee Property Management
Grant in 2017
GuestLee is a Swiss Property Management company. In a exponentially growing market GuestLee positioning settled naturally by trust & recommendation to high-end property owners. 90% of their customers are seniors that worked hard to build real estate assets. With today’s versatile economical environment, living on savings or limited pension allowances, it is quite difficult to sustain life standards as well as to pay property maintenance fees. GuestLee is a decentralized business model using latest technologies to help seniors to generate revenue
Alogo Analysis
Grant in 2017
Alogo Analysis SA is a Swiss company established in 2016, focused on developing advanced analytics tools for the equine industry, particularly in equestrian sports like show-jumping. Based in Apples, Switzerland, Alogo Analysis aims to modernize the discipline by offering innovative solutions that quantify the performance of horses and monitor their health and locomotion. One of its key products, Move, allows users to collect and analyze performance data, facilitating a deeper understanding of equine athletes. By providing novel performance statistics, Alogo Analysis enhances the training experience and improves engagement for spectators and fans at high-level international competitions. Through its commitment to leveraging technology in equestrian sports, the company seeks to elevate the overall experience for both athletes and audiences alike.
Nanogence SA is a Swiss company established in 2017, specializing in the development of innovative material solutions for the construction sector. Based in Renens, the company focuses on creating synthetic, tailor-made materials utilizing advanced nanotechnology and chemistry. Its patented additive formulations enhance the performance of cement and concrete, significantly improving their binding efficiency while also aiming to reduce carbon emissions by up to 50%. By providing environmentally friendly chemicals and additives, Nanogence enables manufacturers in the construction industry to lower costs, enhance durability, and contribute to sustainable practices. The company operates within a rapidly growing global construction market, which underscores the importance of its contributions to more efficient and eco-friendly building materials.
LEDsafari SA, founded in 2014 and based in Lausanne, Switzerland, is a clean-tech company focused on sustainability education and training. The company offers training programs and innovative solar kits designed to help users learn about solar technology and its applications. Through these programs, trainees assemble electrical circuits using the kits and create personalized lamp bodies made from recycled materials. LEDsafari's first product has gained traction in the market, with 15,000 units sold last year across 15 countries via its online platform. The company has developed a state-of-the-art learning platform that includes high-quality animations, graphics, and games, with plans to incorporate augmented reality and mobile technology in the future. By empowering the next generation with practical skills and knowledge, LEDsafari aims to foster a commitment to tackling climate change and promoting sustainable energy practices.
Lymphatica Medtech
Grant in 2017
Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.
Skypull SA is a Swiss company established in 2013, focused on developing an innovative airborne wind energy system that harnesses high-altitude winds to generate electricity. The company has designed a hybrid drone capable of vertical take-off and landing, which operates at greater altitudes where winds are stronger and more consistent. This drone is connected to a ground-based generator via a tether, allowing it to capture and convert wind energy into clean power. Skypull's proprietary airframe technology provides enhanced efficiency and resilience, making the system more versatile than competitors. By leveraging this technology, the company aims to offer an affordable, renewable energy solution that addresses climate change and promotes the transition from fossil fuels to sustainable energy sources.
BAABUK is a Swiss company founded in 2013 by a dynamic couple, Galina and Dan. Their story began when Galina's parents gave Dan a pair of traditional Russian "Valenkis". In the past, these Russian felted boots were essential to fight the Siberian cold. So after trying them out in the snow, Galina and Dan had an idea! Why not preserve the "Valenki" ancestral know-how and create a revised pair of 100% wool shoes? That's when the first BAABUK pair of shoes was born, and they didn't stop there...
RiskTalk Ltd is a company that specializes in developing a communication tool aimed at enhancing employee engagement by allowing them to voice concerns related to their workplace values and priorities. Founded in 2016 and headquartered in Lausanne, Switzerland, with an additional office in Kent, United Kingdom, RiskTalk offers enterprise software that facilitates bottom-up communication, enabling employees to report issues in a blame-free environment. This innovative tool captures and logs risks within organizations, empowering management to allocate responsibilities, provide feedback, and monitor the resolution of problems in real-time. By fostering open dialogue, RiskTalk helps organizations better understand the realities faced by their employees, ultimately turning communication into actionable solutions.
Social Fabric
Grant in 2017
Social Fabric is a sustainable textile center committed to promoting the use of textiles and clothing that minimize ecological and social footprints. The company operates a community-based association that emphasizes the integration of refugees in Switzerland and sustainability in textile production. Through its atelier, Social Fabric aims to provide customers with meaningful and customized garments that reflect principles of a circular economy, innovative technology, and ethical labor practices. By combining decentralised manufacturing with a focus on sustainability, Social Fabric enables individuals to access high-quality, sustainable textile products tailored to their needs.
MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.
ChemAlive SA is a Swiss company founded in 2014 that operates a cloud-based computational chemistry platform. This platform automates the calculation of quantum data for molecular properties and synthetic reactions, allowing chemists to generate accurate analytics from standard 2D chemical inputs. By leveraging managed cloud computing, in-house automation algorithms, and a comprehensive database, ChemAlive provides valuable insights for various sectors, including academic research, pharmaceuticals, fine chemicals, and contract research organizations. The company's services simplify the research and development process, enabling chemists to design experiments more effectively and address complex challenges efficiently. With plans to incorporate machine learning and big data concepts, ChemAlive aims to significantly reduce the time required to obtain reliable chemical information, transforming the way chemists approach their work and enhancing decision-making in chemical sales and marketing environments.
TWIICE is a Swiss company based in Lausanne, founded in 2015, that specializes in the development and manufacture of lower limb exoskeletons. These innovative devices are designed specifically to assist paraplegic individuals in standing and walking again, catering to various morphologies and medical conditions. The exoskeletons feature electric motors that enable movement in the hip and knee joints, providing users with the ability to regain the sensations and benefits associated with standing and walking. TWIICE aims to enhance the independence of individuals with mobility challenges, allowing them to participate more fully in daily activities and improve their overall quality of life.
Sleepiz
Non Equity Assistance in 2017
Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.
Imverse is a Swiss-based 3D graphics software company established in 2017. Headquartered in Plan-les-Ouates, Geneva, the company specializes in deploying volumetric technology for Location Based Entertainment (LBE). Imverse offers real-time simulation and modeling tools that transform 2D images into immersive, 3D virtual environments suitable for live streaming, gaming, and remote work applications. The company's core product is a live volumetric video platform designed for enterprise use, enabling organizations to stream real-time three-dimensional holograms using depth cameras and reality capture software.
Inflight VR Software GmbH
Seed Round in 2017
Inflight VR Software GmbH, founded in 2014 and based in Munich, Germany, specializes in developing virtual reality ecosystems tailored for the inflight entertainment sector. In the wake of the Covid-19 pandemic, airlines face significant challenges and are seeking innovative revenue streams while enhancing passenger satisfaction. The Inflight VR entertainment system offers airlines a way to monetize their services through pay-per-view, advertising, and eCommerce, while providing passengers with an immersive and engaging experience. The technology captures the full attention of travelers, significantly improving their overall journey. Notable clients, including Qatar Airways and Singapore Airlines, demonstrate the system's market viability, with average passenger engagement exceeding 80 minutes and a satisfaction rate above 90%. Each passenger utilizing the Inflight VR system has the potential to generate over €7 in revenue, addressing the substantial demand within the travel industry for enhanced inflight experiences.
TieTalent
Non Equity Assistance in 2017
TieTalent is a Swiss job platform that specializes in connecting companies with qualified professionals in the fields of IT and digital marketing. By leveraging a combination of artificial intelligence, user psychometric data analysis, and human expertise, TieTalent enhances the recruitment process, allowing employers to find suitable candidates more efficiently. The platform prioritizes the candidate experience, eliminating traditional barriers such as motivation letters and unsolicited recruiter calls. This innovative approach aims to simplify and improve the hiring process for both employers and job seekers, making it a more effective and enjoyable experience.
Securaxis
Non Equity Assistance in 2017
Securaxis develops, installs, and operates innovative safety and security solutions, focusing on real-time geolocalized security information. Founded in 2018 as part of the BIC of CERN Technologies in Switzerland, the company is recognized for its achievements, including participation in various startup programs and awards. Securaxis utilizes a smart acoustic sensor connected to a wireless network to analyze and classify sounds in urban environments, allowing for accurate reporting of potential security threats. This technology enables organizations to enhance safety measures by making informed decisions based on real-time data. The team consists of eight experts in machine learning, acoustics, data management, and entrepreneurship, who have successfully developed and commercialized a mobile security application for notable clients, including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations.
Inflight VR Software GmbH
Non Equity Assistance in 2017
Inflight VR Software GmbH, founded in 2014 and based in Munich, Germany, specializes in developing virtual reality ecosystems tailored for the inflight entertainment sector. In the wake of the Covid-19 pandemic, airlines face significant challenges and are seeking innovative revenue streams while enhancing passenger satisfaction. The Inflight VR entertainment system offers airlines a way to monetize their services through pay-per-view, advertising, and eCommerce, while providing passengers with an immersive and engaging experience. The technology captures the full attention of travelers, significantly improving their overall journey. Notable clients, including Qatar Airways and Singapore Airlines, demonstrate the system's market viability, with average passenger engagement exceeding 80 minutes and a satisfaction rate above 90%. Each passenger utilizing the Inflight VR system has the potential to generate over €7 in revenue, addressing the substantial demand within the travel industry for enhanced inflight experiences.
Versantis
Series A in 2017
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.
AirDAO
Non Equity Assistance in 2017
AirDAO is a Swiss-based startup focused on revolutionizing global supply chains via blockchain technology. It operates Ambrosus, an open-source platform designed for decentralized finance (DeFi). AirDAO enables secure, autonomous supply chain management through reliable product history recording and transparent commercial transactions. The platform aims to enhance distribution processes and empower consumers with product origin and composition information. Users can earn token rewards by operating Ambrosus Network validator nodes and accessing innovative dApps via a unified dashboard.
Artmyn SA is a Swiss company specializing in the digitization of visual artworks, providing a comprehensive platform that allows users to interact with high-quality digital replicas of art. Founded in 2015 and based in Belmont-sur-Lausanne, Artmyn offers a range of services including digital guided tours, online galleries, conservation monitoring tools, and interactive e-catalogs. Its unique portable scanner captures extensive data about artworks, enabling true-to-life visualizations accessible via web browsers on various devices. This technology enhances the experience for museums, galleries, auction houses, and both private and institutional collectors, facilitating more transparent transactions in the art market. Artmyn aims to transform the way art is experienced and appreciated through innovative digital solutions.
Versantis
Non Equity Assistance in 2016
Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.
Fastree3D
Non Equity Assistance in 2016
Fastree3D is a fabless semiconductor company founded in September 2013 as a spin-off from EPFL Lausanne, Switzerland. It specializes in the development of three-dimensional imaging sensors that enable real-time recognition and distance measurement of fast-moving objects, facilitating driving assistance and autonomous navigation. The company employs advanced complementary metal-oxide-semiconductor (CMOS) fabrication processes to create precision sensors suitable for both consumer electronics and industrial applications. Fastree3D's technology allows clients to design vehicles and machines capable of continuously monitoring their surroundings, significantly enhancing their ability to detect and locate fast-moving objects in three dimensions. Additionally, Fastree3D B.V., a subsidiary of the company, collaborates with TU-Delft in the Netherlands to further advance its research initiatives.
TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements aimed at enhancing sustainable animal farming practices. Founded in 2015 and based in Root, Switzerland, the company has developed a unique triple active probiotic product that addresses challenges faced in intensive animal farming, such as improving digestion, enhancing feed conversion ratios, and reducing disease and pollution. The probiotic supplement is grounded in research from the École Polytechnique Fédérale de Lausanne, focusing on the enhancement of gut microbiota, which is crucial for food metabolism and immune defense. Targeting animal farmers, feed suppliers, and large retailers, TwentyGreen aims to capture a 10% share of the rapidly growing global animal feed probiotic market, which exceeds $4 billion annually. The commercialization of their product involves rigorous research and development in collaboration with esteemed academic partners to meet regulatory standards for animal feed.
CyanoGuard AG is a Swiss chemical technology company founded in 2016, specializing in innovative solutions for the monitoring and detection of cyanide across various sectors, including mining, food safety, wastewater, and healthcare. The company offers a range of products, including the CyanoKit, a semi-quantitative cyanide test, the CyanoGuard mobile quantitative monitoring test, and the Cyano.iO online monitoring and optimization solution. CyanoGuard's technology enables rapid and accurate cyanide detection without the need for specialized training or equipment, making it suitable for use in remote locations. The company's methods are designed to selectively detect cyanide in liquid samples while resisting interference from common substances, thereby providing clients with efficient tools for tracking and managing cyanide levels in diverse applications.
Gait Up SA is a Swiss company based in Lausanne, founded in 2013 as a spin-off from the University Hospital of Lausanne and the Swiss Institute of Technology. Specializing in motion analytics, Gait Up manufactures wearables used in smartwatches and other hardware to provide objective evaluations of health and performance. With over 15 years of scientific expertise in movement analysis, the company develops innovative products that leverage wearable sensor technology. Gait Up has established a strong presence in the market, serving over 50 customers across academia, clinics, and various industries in Europe, Canada, the United States, and Asia. Since June 2017, Gait Up has operated as a subsidiary of MindMaze SA.
Planet Hort - learning sustainability in a playful way“ is the first organization in Switzerland that aims to integrate Education for Sustainable Development into after-school care. Their activities and courses deal with the five main sustainability topics biodiversity, cultural plurality, consumption, energy and waste. With their program they want to encourage children at an early stage to engage in a sustainable interaction with the environment. And empower day-care personal to adopt their approach. Planet Hort - learning sustainability in a playful way“ wants to integrate Education for Sustainable Development into after-school care.
Eyeware
Non Equity Assistance in 2016
Eyeware Tech SA, established in 2016 in Martigny, Switzerland, specializes in developing software for eye tracking using standard webcams and 3D cameras. Its flagship product, GazeSense, enables accurate gaze tracking, facilitating applications across industries such as automotive, healthcare, gaming, and robotics. Eyeware's platform-independent technology improves upon previous hardware-based solutions by offering a cost-effective and reliable alternative for integrating head and eye tracking into consumer devices.
Smart Home Technology
Grant in 2016
Smart Home Technology GmbH, founded in 2014 and based in Zurich, Switzerland, specializes in the development of smart devices and home automation products. The company is dedicated to enhancing existing systems by providing ultra-low power, reliable, and cost-effective solutions derived from scientific research and advanced technological expertise. Smart Home Technology employs zero-standby power technology, enabling the operation of electrical devices and household appliances with no standby energy losses. By focusing on security and communication concepts, the company offers highly efficient systems integrated with smart software, catering primarily to business customers in the cleantech and smart home sectors.
SwissDeCode is a Swiss company based in Renens that specializes in food safety and compliance services for food manufacturers. Founded in 2016, it offers rapid onsite DNA testing solutions that allow production facilities to confirm food authenticity, safety, and origin. By providing plug-and-play systems, SwissDeCode enables factories to obtain food safety and quality certifications within the same work shift, facilitating immediate decision-making for inspectors. This approach not only addresses contamination threats but also transforms them into sustainable opportunities for food producers.
Includeed is a consultancy and innovative solution provider focused on diversity and inclusion, particularly addressing gender-related issues. Founded in 2015 and headquartered in Les Acacias, Switzerland, the company operates a platform where employees, job seekers, and customers can review experiences, share stories, ask questions, suggest solutions, and request disclosure of data regarding diversity and equal opportunities from organizations. Includeed also runs programs in major cities including Geneva, Zurich, Paris, and Lyon, aiming to foster more inclusive workplaces and promote equitable practices across various sectors.
Fastree3D
Angel Round in 2016
Fastree3D is a fabless semiconductor company founded in September 2013 as a spin-off from EPFL Lausanne, Switzerland. It specializes in the development of three-dimensional imaging sensors that enable real-time recognition and distance measurement of fast-moving objects, facilitating driving assistance and autonomous navigation. The company employs advanced complementary metal-oxide-semiconductor (CMOS) fabrication processes to create precision sensors suitable for both consumer electronics and industrial applications. Fastree3D's technology allows clients to design vehicles and machines capable of continuously monitoring their surroundings, significantly enhancing their ability to detect and locate fast-moving objects in three dimensions. Additionally, Fastree3D B.V., a subsidiary of the company, collaborates with TU-Delft in the Netherlands to further advance its research initiatives.
Artmyn
Non Equity Assistance in 2016
Artmyn SA is a Swiss company specializing in the digitization of visual artworks, providing a comprehensive platform that allows users to interact with high-quality digital replicas of art. Founded in 2015 and based in Belmont-sur-Lausanne, Artmyn offers a range of services including digital guided tours, online galleries, conservation monitoring tools, and interactive e-catalogs. Its unique portable scanner captures extensive data about artworks, enabling true-to-life visualizations accessible via web browsers on various devices. This technology enhances the experience for museums, galleries, auction houses, and both private and institutional collectors, facilitating more transparent transactions in the art market. Artmyn aims to transform the way art is experienced and appreciated through innovative digital solutions.
Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.
Rayform
Non Equity Assistance in 2016
Rayform SA is a Swiss company specializing in innovative light redirection technology that enables unique design possibilities for luxury products and packaging. Founded in 2016 and based in Ecublens, the company employs a proprietary computer algorithm to calculate the three-dimensional surfaces necessary for creating target images from light. By modifying the shape of transparent or reflective surfaces according to the algorithm's specifications, Rayform's technology redirects incoming light to produce clear and detailed images on adjacent surfaces. This capability not only enhances the visual appeal of consumer products but also aids artists, designers, and brands in crafting memorable experiences while providing a means to combat counterfeiting.
Rqmicro
Non Equity Assistance in 2016
Rqmicro is a Swiss company based in Zurich, founded in 2013, that specializes in pathogen separation and detection technology. The company has developed proprietary reagents and instruments for rapid microbiological testing, which provide accurate results in under one hour. Rqmicro's technology is utilized for the rapid assessment of water and food safety, enabling clients to detect dangerous pathogens effectively. By delivering quantitative data on contamination, Rqmicro's solutions enhance the overall safety of water and food products, addressing critical public health concerns.
Pingen is an online solution to send documents by letter post for private, business, and software integration. Users can either upload PDFs from their desktops or fetch files online from their Dropbox, Google Drive, and Microsoft Skydrive accounts. Pingen was launched in 2010 and is operated from Zürich, Switzerland.
incredX AG is a Swiss-based healthcare company founded in 2011 by a small team of former executives and surgeons from the AO Foundation. The company focuses on leveraging modern technologies to create a universal platform for recording, tracking, and sharing Patient Outcome Measures across global healthcare systems. incredX develops a cloud-based healthcare system that facilitates collaboration among medical professionals and patients, allowing them to exchange treatment and outcome data effectively. This innovative approach enables healthcare providers to quickly identify and adopt proven best practices, ultimately aiming to improve patient care and outcomes.
MagnebotiX, founded in 2014 and based in Zurich, specializes in the development and production of advanced magnetic manipulation systems. The company focuses on creating magnetic field generators and micromagnetic agents, utilizing their extensive expertise in the field. Their innovative products are designed to facilitate both fundamental and applied scientific research, enabling users to perform complex micromanipulation tasks wirelessly. MagnebotiX’s systems are particularly valuable as untethered mechanical probes, allowing access to otherwise unreachable areas and enabling targeted cargo delivery for minimally invasive biological studies. By leveraging the transmission of power and guidance through applied magnetic fields, MagnebotiX supports a wide range of research applications in the field of magnetic phenomena and magnetic microrobots.
Biowatch
Non Equity Assistance in 2015
Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.